Valuation : Alcon Inc.

Market Cap 35.16B 30.18B 28.26B 25.88B 48.75B 3,358B 48.89B 335B 131B 1,693B 132B 129B 5,602B P/E 2026 *
43.5x
P/E 2027 * 26.4x
Enterprise Value 37.71B 32.37B 30.3B 27.75B 52.27B 3,601B 52.42B 359B 140B 1,815B 142B 139B 6,007B EV / Sales 2026 *
3.4x
EV / Sales 2027 * 3.11x
Free-Float
97.34%
Yield 2026 *
0.51%
Yield 2027 * 0.57%
1 week-0.67%
Current month+3.68%
1 month+4.87%
3 months+8.69%
6 months-16.01%
Current year-9.19%
1 week 61.74
Extreme 61.74
63.52
1 month 58.92
Extreme 58.92
66.78
Manager TitleAgeSince
Chief Executive Officer 60 01/07/2018
Director of Finance/CFO 58 08/04/2019
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 01/07/2018
Director/Board Member 63 01/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.19%-0.67%-11.35% - 35.16B
+3.17%-0.49%-38.34%-7.79% 84.33B
-0.79%-1.05%-8.75%-21.55% 35.16B
-2.37%-6.83%-4.24%-23.57% 13.84B
-0.17%-0.03% - - 11.66B
+2.58%+13.26%-7.14%+727.42% 2.73B
+2.33%-2.66%-42.86%-56.92% 1.47B
+1.78%+3.04%+16.95%+10.70% 909M
+4.93%-0.40%-40.89%-13.44% 887M
+1.09%+2.67% - - 901M
Average +1.37%+0.60%-17.08%+87.84% 16.88B
Weighted average by Cap. +1.40%-2.00%-23.51%+1.12%

Financials

2026 *2027 *
Net sales 11.09B 9.52B 8.91B 8.16B 15.37B 1,059B 15.42B 106B 41.25B 534B 41.63B 40.73B 1,767B 11.77B 10.11B 9.46B 8.66B 16.32B 1,124B 16.37B 112B 43.8B 567B 44.2B 43.25B 1,876B
Net income 764M 656M 614M 562M 1.06B 72.99B 1.06B 7.27B 2.84B 36.79B 2.87B 2.81B 122B 1.26B 1.08B 1.01B 926M 1.75B 120B 1.75B 11.98B 4.68B 60.6B 4.73B 4.62B 201B
Net Debt 2.54B 2.18B 2.05B 1.87B 3.53B 243B 3.54B 24.22B 9.47B 122B 9.55B 9.35B 405B 1.45B 1.24B 1.17B 1.07B 2.01B 138B 2.02B 13.8B 5.39B 69.79B 5.44B 5.33B 231B
Logo Alcon Inc.
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
-
Date Price Change
28/08/26 61.90 -0.19%
27/08/26 €62.02 -0.58%
26/08/26 €62.38 -0.83%
25/08/26 €62.90 -0.54%
24/08/26 €63.24 +0.25%
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
72.74USD
Average target price
91.39USD
Spread / Average Target
+25.63%

Quarterly revenue - Rate of surprise